The Americas Technical Advisory Group (ATAG) was established in 1994. Its purpose is to advise ICCBBA on the needs of users in the Americas.
The ATAG membership is drawn from experts and representatives in the field of transfusion medicine working in the Americas in facilities that are licensed with ICCBBA.
In addition to voting members, liaisons attend ATAG meetings. Liaisons are from regulatory authorities and organizations with an interest in the ISBT 128 Standard.
Vendors and others interested in the work of the group may attend meetings as observers at the discretion of the chairperson.
Summary of Recent Activity
ATAG discussed Proposal 19-001 which is a proposal to specify the location of a 2-D symbol on an ISBT 128 base label (if a 2-D symbol is used). The proposal suggests that the 2-D symbol be printed in the upper right quadrant of the 100mm x 106mm base label. The group agreed that an ICCBBA-defined compound messages be used in the 2-D symbol.
The group reviewed Proposal 19-002 which proposes a new data structure that allows users to encode the Product Description Codes (PDCs) of the constituent elements of a combination product. This is particularly needed for regenerative medicine products (e.g., regenerated trachea) where various constituent elements such as cells and scaffolds are combined and some of them might already be identified by a PDC. This allows end-users to know the greater detail provided by the PDC of the individual elements.
The group discussed promoting the use of ISBT 128 identifiers in Electronic Health Records for the purpose of recording MPHO traceability information. The goal is to develop a standard XML message that provides information about an MPHO product and allow for the electronic transfer of the information between blood centers and hospitals.
ATAG recently formed the IG-002 US Consensus Standard Subcommittee to work on proposed updates and guidance for the next version of the US Consensus Standard for Blood (IG-002) scheduled to be published in 2021.
The US Platelet Labeling Subcommittee was formed to develop a solution for platelet labeling and coding that would comply with the new 2019 FDA Guidance – Bacterial Risk Control Strategies for Blood Collection Facilities and Transfusion Services to Enhance the Safety and Availability of Platelets for Transfusion.
No face-to-face meetings are currently scheduled for ATAG.
• Suzanne Butch
• Chester Alexander - Department of Defense
• Donald Gironne -Héma-Québec
• Wanda Lefresne - Canadian Blood Services
• Maria Locher - American Red Cross
• Lucinda Olivio - America's Blood Centers
• Mary Plut - America's Blood Centers (Alt.)
• Jessica Poisson - AABB IS Committee
• Kathleen Hopping
• Carrie VanStedum
• Robin Wilkinson
• Travis Berry
• Geoff Browne
• Troy Campbell
• Tina Chavez
• Ashley Davis
• Jeff Dragoo
• John Gorowsky
• Helmut Hanske
• Brenda Heiman
• Nancy Luckemeyer
• Kent Kirimli
• Brian Kirkpatrick
• John Kling
• Carolina Lied Sanabia
• Ben Marchlewicz
• Gilles Polnicky
• Heather Reddy
• Neal Rowland
• Stephane Sajot
• Renae Weaver
• Leif Sandvik
• Laurie Sapp
• Marsha Senter
• Tiffiney Teo
• Daniel Waurzyniak
• Elan Weiner
• Bruce Wray
• Francisca Agbanyo - Health Canada
• Barbara Peoples - U.S. Food and Drug Administration
• Patricia Weddington - U.S. Food and Drug Administration (Alt.)
ICCBBA Staff Liaison
• Erwin Cabana